180 related articles for article (PubMed ID: 15385295)
21. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation.
de Baère T; Palussière J; Aupérin A; Hakime A; Abdel-Rehim M; Kind M; Dromain C; Ravaud A; Tebboune N; Boige V; Malka D; Lafont C; Ducreux M
Radiology; 2006 Aug; 240(2):587-96. PubMed ID: 16864679
[TBL] [Abstract][Full Text] [Related]
22. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation.
Beland MD; Wasser EJ; Mayo-Smith WW; Dupuy DE
Radiology; 2010 Jan; 254(1):301-7. PubMed ID: 20032160
[TBL] [Abstract][Full Text] [Related]
23. [Percutaneous CT-guided high-dose brachytherapy (CT-HDRBT) ablation of primary and metastatic lung tumors in nonsurgical candidates].
Collettini F; Schnapauff D; Poellinger A; Denecke T; Banzer J; Golenia MJ; Wust P; Gebauer B
Rofo; 2012 Apr; 184(4):316-23. PubMed ID: 22297915
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for occurrence of local tumor progression after percutaneous radiofrequency ablation for lung neoplasms.
Yamagami T; Kato T; Hirota T; Yoshimatsu R; Matsumoto T; Shimada J; Nishimura T
Diagn Interv Radiol; 2007 Dec; 13(4):199-203. PubMed ID: 18092293
[TBL] [Abstract][Full Text] [Related]
25. Adrenal neoplasms: CT-guided radiofrequency ablation--preliminary results.
Mayo-Smith WW; Dupuy DE
Radiology; 2004 Apr; 231(1):225-30. PubMed ID: 14990812
[TBL] [Abstract][Full Text] [Related]
26. Imaging-guided radiofrequency ablation of solid renal tumors.
Farrell MA; Charboneau WJ; DiMarco DS; Chow GK; Zincke H; Callstrom MR; Lewis BD; Lee RA; Reading CC
AJR Am J Roentgenol; 2003 Jun; 180(6):1509-13. PubMed ID: 12760910
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous radiofrequency ablation of lung cancer presenting as ground-glass opacity.
Iguchi T; Hiraki T; Gobara H; Fujiwara H; Matsui Y; Soh J; Toyooka S; Kiura K; Kanazawa S
Cardiovasc Intervent Radiol; 2015 Apr; 38(2):409-15. PubMed ID: 24938905
[TBL] [Abstract][Full Text] [Related]
28. Radiofrequency ablation of lung metastases close to large vessels during vascular occlusion: preliminary experience.
de Baere T; Robinson JM; Rao P; Teriitehau C; Deschamps F
J Vasc Interv Radiol; 2011 Jun; 22(6):749-54. PubMed ID: 21616429
[TBL] [Abstract][Full Text] [Related]
29. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates.
Fernando HC; De Hoyos A; Landreneau RJ; Gilbert S; Gooding WE; Buenaventura PO; Christie NA; Belani C; Luketich JD
J Thorac Cardiovasc Surg; 2005 Mar; 129(3):639-44. PubMed ID: 15746749
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report.
Lee JM; Jin GY; Goldberg SN; Lee YC; Chung GH; Han YM; Lee SY; Kim CS
Radiology; 2004 Jan; 230(1):125-34. PubMed ID: 14645875
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous radiofrequency thermal ablation of primary and metastatic lung tumors.
Thanos L; Mylona S; Pomoni M; Athanassiadi K; Theakos N; Zoganas L; Batakis N
Eur J Cardiothorac Surg; 2006 Nov; 30(5):797-800. PubMed ID: 17000115
[TBL] [Abstract][Full Text] [Related]
32. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
[TBL] [Abstract][Full Text] [Related]
33. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
[TBL] [Abstract][Full Text] [Related]
34. Morphologic and functional changes in nontumorous liver tissue after radiofrequency ablation in an in vivo model: comparison of 18F-FDG PET/CT, MRI, ultrasound, and CT.
Vogt FM; Antoch G; Veit P; Freudenberg LS; Blechschmid N; Diersch O; Bockisch A; Barkhausen J; Kuehl H
J Nucl Med; 2007 Nov; 48(11):1836-44. PubMed ID: 17942811
[TBL] [Abstract][Full Text] [Related]
35. Computed tomographic appearance of lung tumors treated with percutaneous cryoablation.
Ito N; Nakatsuka S; Inoue M; Yashiro H; Oguro S; Izumi Y; Kawamura M; Nomori H; Kuribayashi S
J Vasc Interv Radiol; 2012 Aug; 23(8):1043-52. PubMed ID: 22840803
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response.
Akeboshi M; Yamakado K; Nakatsuka A; Hataji O; Taguchi O; Takao M; Takeda K
J Vasc Interv Radiol; 2004 May; 15(5):463-70. PubMed ID: 15126656
[TBL] [Abstract][Full Text] [Related]
37. Creation of radiofrequency lesions in a porcine model: correlation with sonography, CT, and histopathology.
Raman SS; Lu DS; Vodopich DJ; Sayre J; Lassman C
AJR Am J Roentgenol; 2000 Nov; 175(5):1253-8. PubMed ID: 11044017
[TBL] [Abstract][Full Text] [Related]
38. Indeterminate solitary pulmonary nodules revealed at population-based CT screening of the lung: using first follow-up diagnostic CT to differentiate benign and malignant lesions.
Takashima S; Sone S; Li F; Maruyama Y; Hasegawa M; Kadoya M
AJR Am J Roentgenol; 2003 May; 180(5):1255-63. PubMed ID: 12704034
[TBL] [Abstract][Full Text] [Related]
39. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study).
Lencioni R; Crocetti L; Cioni R; Suh R; Glenn D; Regge D; Helmberger T; Gillams AR; Frilling A; Ambrogi M; Bartolozzi C; Mussi A
Lancet Oncol; 2008 Jul; 9(7):621-8. PubMed ID: 18565793
[TBL] [Abstract][Full Text] [Related]
40. CT-guided thin needles percutaneous cryoablation (PCA) in patients with primary and secondary lung tumors: a preliminary experience.
Pusceddu C; Sotgia B; Fele RM; Melis L
Eur J Radiol; 2013 May; 82(5):e246-53. PubMed ID: 23394762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
